采纳股份收盘下跌1.82%，滚动市盈率70.31倍，总市值25.12亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Canan Technology Co., Ltd., which operates in the medical device industry [1][2] - As of May 22, Canan's stock closed at 20.55 yuan, down 1.82%, with a rolling PE ratio of 70.31 times, and a total market capitalization of 2.512 billion yuan [1] - The average PE ratio for the medical device industry is 48.71 times, with a median of 35.37 times, placing Canan at the 100th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, five institutions hold shares in Canan, with a total of 25.8895 million shares valued at 571 million yuan [1] - Canan's main business includes the research, production, and sales of injection and puncture devices and laboratory consumables, recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province [1] - The latest financial results for the first quarter of 2025 show that Canan achieved operating revenue of 72.7093 million yuan, a year-on-year decrease of 34.28%, and a net profit of 7.6802 million yuan, down 69.34%, with a gross profit margin of 31.15% [1]